TransportationWaymo Outsources Dallas Robotaxi Fleet to Avis as Global AV Firms Shift from Vertical IntegrationFeb 22, 2026
BusinessEnterprise AI Platforms Process 51 Billion API Calls as US Tech Giants Battle for Global Market ShareFeb 22, 2026
Real EstateUS Healthcare REIT Locks $122.5M Acquisitions at 9%+ Yields Without Equity DilutionFeb 22, 2026
TechnologyDeep Learning Trading Systems Spread From Wall Street to Retail Platforms Across 50+ CountriesFeb 22, 2026
artificial-intelligenceMeta Boosts AI Spending While Autonomous Vehicle Research Tackles Explainability GapFeb 22, 2026
Central BankingFed Holds Rates High as $100B Stimulus Package Revives Inflation Fears GloballyFeb 22, 2026
MarketsPrivate Equity Targets Packaging Assets Across Markets as Earnings Season Reveals 20% Swings in Tech ValuationsFeb 22, 2026
Digital AssetsStrategy Inc's $54.5B Bitcoin Hoard Dwarfs National Reserves, Exposes Custody VoidFeb 22, 2026
Corporate FinanceQuikrete's $11.5B Summit Materials Bid Tests U.S. Antitrust Limits as Global Construction Consolidation AcceleratesFeb 22, 2026
TechnologyAI Chip Tester Projects $60-80M Orders as Custom Silicon Race Spreads Beyond US GiantsFeb 22, 2026
financial-regulationTexas CEO Nate Paul Convicted of Wire Fraud in $172M Real Estate SchemeFeb 22, 2026
Central BankingFed Holds Rates as Global Central Banks Diverge: Markets See 51% Chance of June CutFeb 22, 2026
currenciesDollar Hits 2022 Low as Euro Surges 14%, Reshaping $6.6 Trillion Daily FX MarketFeb 22, 2026
biotechnologyLeonaBio Risks $140M Market Cap on Single Breast Cancer Trial After Neurodegenerative PivotFeb 22, 2026
defense-industryU.S. Defense Contractor Espey Faces 80% Revenue Concentration Risk as Global Military Budgets ShiftFeb 22, 2026
EconomyU.S. spending bill risks $5.5 trillion debt surge, threatens Social Security by 2032 amid global fiscal pressuresFeb 22, 2026
Corporate FinanceStrive Acquires Bitcoin-Holding Semler, Adding 123 BTC in Corporate Treasury Test CaseFeb 22, 2026
Healthcare & PharmaceuticalsQuest Diagnostics' Haystack Oncology Deal Faces Repricing Risk as Validation Gaps Threaten $8B Liquid Biopsy Market EntryFeb 22, 2026
